Chemoinformaics analysis of 7,3,4-TRIHYDROXY-3,8-DIMETHOXYFLAVONE
| Molecular Weight | 330.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 18 |
| Exact Molecular Weight | 330.074 | nRing | 3 |
| Solubility: LogS | -3.948 | nHRing | 1 |
| Solubility: LogP | 2.614 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 3 | BPOL | 20.1209 |
| QED | 0.633 |
| Synth | 2.498 |
| Natural Product Likeliness | 1.26 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.94 |
| Pgp-sub | 0.001 |
| HIA | 0.027 |
| CACO-2 | -4.94 |
| MDCK | 0.0000151 |
| BBB | 0.008 |
| PPB | 0.925379 |
| VDSS | 0.63 |
| FU | 0.1243 |
| CYP1A2-inh | 0.934 |
| CYP1A2-sub | 0.897 |
| CYP2c19-inh | 0.13 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.603 |
| CYP2c9-sub | 0.784 |
| CYP2d6-inh | 0.262 |
| CYP2d6-sub | 0.34 |
| CYP3a4-inh | 0.402 |
| CYP3a4-sub | 0.17 |
| CL | 8.619 |
| T12 | 0.908 |
| hERG | 0.009 |
| Ames | 0.744 |
| ROA | 0.366 |
| SkinSen | 0.75 |
| Carcinogencity | 0.332 |
| EI | 0.901 |
| Respiratory | 0.218 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.859939 |